Integer Holdings Co. (NYSE:ITGR) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Integer Holdings Co. (NYSE:ITGRGet Free Report) have earned an average rating of “Moderate Buy” from the seven ratings firms that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $128.00.

Several research firms have weighed in on ITGR. Bank of America upgraded Integer from a “neutral” rating to a “buy” rating and boosted their price target for the company from $105.00 to $135.00 in a research note on Monday, April 15th. Benchmark reiterated a “buy” rating and issued a $130.00 price target on shares of Integer in a report on Friday, May 10th. CL King started coverage on shares of Integer in a research report on Thursday, March 14th. They set a “buy” rating and a $137.00 price target for the company. Citigroup upped their price objective on shares of Integer from $118.00 to $124.00 and gave the company a “neutral” rating in a report on Wednesday, May 22nd. Finally, KeyCorp raised their target price on shares of Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th.

Check Out Our Latest Analysis on ITGR

Insider Buying and Selling

In other news, SVP Andrew Senn sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $113.14, for a total transaction of $565,700.00. Following the sale, the senior vice president now directly owns 4,658 shares in the company, valued at approximately $527,006.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, SVP Andrew Senn sold 5,000 shares of Integer stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $113.14, for a total value of $565,700.00. Following the sale, the senior vice president now owns 4,658 shares of the company’s stock, valued at approximately $527,006.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP John A. Harris sold 1,521 shares of the company’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $120.44, for a total transaction of $183,189.24. Following the transaction, the executive vice president now owns 4,922 shares of the company’s stock, valued at $592,805.68. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,936 shares of company stock valued at $2,130,937. Corporate insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integer

Several institutional investors have recently bought and sold shares of the company. Blue Trust Inc. boosted its stake in Integer by 483.3% during the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 377 shares during the last quarter. Principal Securities Inc. acquired a new position in Integer during the fourth quarter worth about $67,000. Headlands Technologies LLC purchased a new stake in Integer during the 1st quarter valued at about $106,000. Quadrant Capital Group LLC raised its holdings in Integer by 10.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock valued at $141,000 after acquiring an additional 132 shares during the last quarter. Finally, Strs Ohio raised its holdings in Integer by 54.5% in the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock valued at $168,000 after acquiring an additional 600 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Price Performance

Shares of ITGR stock opened at $121.11 on Monday. The firm has a market capitalization of $4.06 billion, a price-to-earnings ratio of 41.91, a PEG ratio of 1.79 and a beta of 1.16. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.01 and a current ratio of 3.32. The stock’s 50-day simple moving average is $117.07 and its 200-day simple moving average is $107.65. Integer has a fifty-two week low of $69.40 and a fifty-two week high of $123.99.

Integer (NYSE:ITGRGet Free Report) last issued its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.12 by $0.02. Integer had a net margin of 6.01% and a return on equity of 11.25%. The business had revenue of $414.80 million for the quarter, compared to analyst estimates of $412.78 million. During the same quarter in the prior year, the business posted $0.87 EPS. Integer’s revenue for the quarter was up 9.5% compared to the same quarter last year. As a group, equities analysts forecast that Integer will post 5.27 earnings per share for the current fiscal year.

About Integer

(Get Free Report

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Read More

Analyst Recommendations for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.